Non-Hodgkin lymphoma is a type of cancer that forms in the lymph system, which is part of the body’s immune system. The immune system protects the body from foreign substances, infection, and diseases. The lymph system is made up of the following lymphocytes: B lymphocytes, T lymphocytes, and Natural Killer Cells.
Non-Hodgkin lymphoma can begin in B lymphocytes, T lymphocytes, or natural killer cells. Lymphocytes can also be found in the blood and also collect in the lymph nodes, spleen, and thymus. — National Cancer Institute
Prospective Analysis of Safety and Efficacy of Medical Cannabis in Large Unselected Population of Patients with Cancer
Below is a Library of Cannabis Research Study for Non-Hodgkin’s Lymphoma.
Over 1000 studies covering over 130 topics compiled for easy browsing.
Among the cellular events involved in glioma cell death, CBD produced a time-dependent release of cytochrome C and activation of caspase-8, −9 and −3, suggesting the involvement of both the intrinsic and extrinsic apoptotic pathways . Marcu et al.  later confirmed the efficacy of CBD in inhibiting the growth of multiple glioblastoma cell lines in a more potent way than Δ 9 -THC. Interestingly, combined treatment of Δ 9 -THC with CBD demonstrated that CBD enhanced the Δ 9 -THC inhibitory effect on glioblastoma cell growth, but not on invasiveness . In line with this, more recently Torres et al.  confirmed that combined treatment with CBD and Δ 9 -THC greatly reduced human glioma cell viability enhancing both autophagy and apoptosis and triggering caspase-3 activation. Moreover, combined administration of submaximal doses of CBD and Δ 9 -THC reduced the growth of U87-MG cell-derived tumour xenografts in nude mice to a greater extent than treatment with the individual compounds, suggesting the potential use of combination therapy which would reduce the amount of the psychoactive Δ 9 -THC.
After the seminal paper of Jacobsson et al.  demonstrating a serum-dependent effect of CBD upon C6 murine glioma cell proliferation, Massi et al. in 2004  reported that CBD was effective in inhibiting U87-MG and U373 human glioma cell proliferation in vitro through the induction of apoptosis. Interestingly, CBD did not affect viability of non-transformed primary glial cells . When tumour xenografts were generated in immune-deficient mice, in vivo intratumoural treatment with CBD significantly reduced tumour growth .
CBD and leukaemia/lymphoma
Together, these findings provide a novel mechanism underlying the anti-invasive action of CBD on human lung cancer cells and imply its use as a therapeutic option for the treatment of highly invasive cancers.
In the light of its safety records, these results suggest that CBD might be worthy of clinical consideration in colon cancer prevention.
NC = not checked. ↑ increase; ↓ decrease.
In non-Hodgkin’s lymphoma, tumors develop from white blood cells called lymphocytes, often at different locations in your body. Normally, lymphocytes go through a predictable life cycle. Old lymphocytes die and your body creates new ones to replace them. But in non-Hodgkin’s lymphoma, your body produces abnormal lymphocytes that continue to divide and grow without control. This excess of lymphocytes crowds into your lymph nodes, causing them to swell.
Hodgkin’s lymphoma, cells in the lymphatic system grow abnormally and may spread beyond the lymphatic system. As the condition progresses, it compromises your body’s ability to fight infection and symptoms appear. Many symptoms may be similar to those of flu, such as fever, fatigue and night sweats. Eventually, tumors develop. Hodgkin’s lymphoma usually affects people between the ages of 15 to 35 and those older than 55.
Lymphoma is a general term for cancer that develops in the lymphatic system, the part of your immune system that helps fight disease and infection. Specifically, it is a cancer of immune cells called lymphocytes, a type of white blood cell. There are two broad types of lymphoma – Hodgkin’s or non-Hodgkin’s.
Lymphoma can occur at any age but is the most common cancer in young people.